Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium

  1. Beer, T.M.
  2. Smith, D.C.
  3. Hussain, A.
  4. Alonso, M.
  5. Wang, J.
  6. Giurescu, M.
  7. Roth, K.
  8. Wang, Y.
Journal:
British Journal of Cancer

ISSN: 0007-0920,  1532-1827

Year of publication: 2012

Volume: 107

Issue: 5

Pages: 808-813

Type: Article

DOI: 10.1038/BJC.2012.339 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus